The criteria for the novelty and inventive step of pharmaceutical selection inventions (T 1356/21)
The IPKat
DECEMBER 13, 2023
The case related to the novelty and inventive step of a second medical use claim. The Board of Appeal considered the appropriate application of EPO case law on the novelty of dosage regimes and selection inventions, and the reliance on an unexpected technical effect for inventive step.
Let's personalize your content